The session highlighted China’s rapid sector growth driven by innovation, investment, and healthcare transformation, while also addressing key barriers such as regulatory complexity and market entry strategy.

Drawing on recent transaction experience, including a strategic investment involving OncoZenge AB, the presentation provided practical insights into cross-border collaboration and market access.

Source: LinkedIn